MAIA Biotechnology Files 8-K: Material Agreement & Equity Sales
Ticker: MAIA · Form: 8-K · Filed: Feb 19, 2025 · CIK: 1878313
| Field | Detail |
|---|---|
| Company | Maia Biotechnology, INC. (MAIA) |
| Form Type | 8-K |
| Filed Date | Feb 19, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, 8-k
TL;DR
MAIA Bio inked a big deal and sold some stock, filing an 8-K on 2/18/25.
AI Summary
MAIA Biotechnology, Inc. announced on February 18, 2025, that it entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and other events. This filing includes financial statements and exhibits.
Why It Matters
This 8-K filing indicates significant corporate activity for MAIA Biotechnology, including a new material agreement and equity transactions, which could impact its financial standing and future operations.
Risk Assessment
Risk Level: medium — The filing details a material definitive agreement and unregistered sales of equity, which can introduce financial and operational risks.
Key Players & Entities
- MAIA Biotechnology, Inc. (company) — Registrant
- February 18, 2025 (date) — Date of earliest event reported
- 444 West Lake Street, Suite 1700 Chicago, IL 60606 (address) — Principal executive offices
FAQ
What is the nature of the material definitive agreement entered into by MAIA Biotechnology, Inc.?
The filing does not specify the details of the material definitive agreement, only that one was entered into on or before February 18, 2025.
What type of equity securities were sold unregistered?
The filing mentions unregistered sales of equity securities but does not provide specific details about the type or amount of securities sold.
What are the key financial statements and exhibits included in this filing?
The filing indicates that financial statements and exhibits are included, but their specific content is not detailed in the provided text.
When was the earliest event reported in this Form 8-K?
The earliest event reported in this Form 8-K occurred on February 18, 2025.
What is MAIA Biotechnology, Inc.'s state of incorporation and IRS Employer Identification Number?
MAIA Biotechnology, Inc. is incorporated in Delaware and its IRS Employer Identification Number is 83-1495913.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 19, 2025 regarding MAIA Biotechnology, Inc. (MAIA).